Compugen Ltd Stock Prediction
AI-powered sentiment analysis and prediction trends for CGEN, updated each market day.
CGEN AI Sentiment
AI predicts Compugen Ltd stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Compugen Ltd
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Exchange
Market Cap
$234,494,234
Cap Tier
Employees
75
Listed Since
Aug. 11, 2000
Website
CGEN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CGEN Volatility
Compugen Ltd has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
